Business Development
Business Development
Objective
Objective
Turn pipeline and market insight into a disciplined BD engine that aligns strategy, partnerships and communication so each product is credibly positioned and drives near- and long-term value.
Turn pipeline and market insight into a disciplined BD engine that aligns strategy, partnerships and communication so each product is credibly positioned and drives near- and long-term value.
Partnering Strategy
We provide a list of potential partners which we are already in touch with.
Segment and prioritise geographies, clinical settings and KOL networks per product(line).
Build a qualified longlist/shortlist of strategic partners (MNCs, regional champions, speciality distributors, co-dev candidates, PE-backed platforms).
Design partnering constructs (distribution, licensing, co-promotion, co-development) matched to evidence maturity, regulatory status and growth ambitions.
Align BD, commercial and marketing so all activity follows a clear thesis, not ad hoc requests.
Partnering Strategy
We provide a list of potential partners which we are already in touch with.
Segment and prioritise geographies, clinical settings and KOL networks per product(line).
Build a qualified longlist/shortlist of strategic partners (MNCs, regional champions, speciality distributors, co-dev candidates, PE-backed platforms).
Design partnering constructs (distribution, licensing, co-promotion, co-development) matched to evidence maturity, regulatory status and growth ambitions.
Align BD, commercial and marketing so all activity follows a clear thesis, not ad hoc requests.
Stakeholder Narrative
We tell the story to maximize potential interest from the other party.
Translate clinical, health-economic and usability data into stakeholder-specific value propositions for clinicians, procurement, payers, KOLs and partners.
Position products within care pathways, workflows and budget constraints, showing why adoption is rational, low-risk and scalable.
Deliver consistent, compliant, evidence-led materials (partner deck, one-pagers, summaries) to reduce friction in evaluations and internal sign-offs.
Stakeholder Narrative
We tell the story to maximize potential interest from the other party.
Translate clinical, health-economic and usability data into stakeholder-specific value propositions for clinicians, procurement, payers, KOLs and partners.
Position products within care pathways, workflows and budget constraints, showing why adoption is rational, low-risk and scalable.
Deliver consistent, compliant, evidence-led materials (partner deck, one-pagers, summaries) to reduce friction in evaluations and internal sign-offs.
Investor & Strategic Partner Positioning
We present your assets as a credible, scalable investment and partnership platform.
Tailor narratives and outreach for regional and global partners, aligned with local access dynamics and regulatory frameworks.
Lead initial outreach and discussions to confirm interest and strategic fit, then support design and negotiation of preferred deal structures aligned with your strategic and financial objectives.
Investor & Strategic Partner Positioning
We present your assets as a credible, scalable investment and partnership platform.
Tailor narratives and outreach for regional and global partners, aligned with local access dynamics and regulatory frameworks.
Lead initial outreach and discussions to confirm interest and strategic fit, then support design and negotiation of preferred deal structures aligned with your strategic and financial objectives.
Action Plan, Execution & Governance
We run a visible, accountable BD motion.
0–6 months: prioritised target list, outreach plan, first meetings, feedback loops, early term options.
6–24 months: advance qualified opportunities to pilots, LOIs, licensing/distribution agreements, refine economics and operational implications.
Maintain a BD funnel, reporting and review cadence so leadership sees status, risks and next actions.
Provide hands-on deal support: preparation, scenarios, negotiation levers, internal alignment.
Action Plan, Execution & Governance
We run a visible, accountable BD motion.
0–6 months: prioritised target list, outreach plan, first meetings, feedback loops, early term options.
6–24 months: advance qualified opportunities to pilots, LOIs, licensing/distribution agreements, refine economics and operational implications.
Maintain a BD funnel, reporting and review cadence so leadership sees status, risks and next actions.
Provide hands-on deal support: preparation, scenarios, negotiation levers, internal alignment.
Long-Term Growth Architecture
We ensure BD becomes a system, not a one-off project.
Establish a pragmatic BD operating model: stages, qualification criteria, ownership, decision gates.
Integrate BD with regulatory, clinical, market access and marketing, ensuring promises are deliverable and reputational risk controlled.
Keep all partnering decisions anchored in evidence strength, compliance and long-term value creation.
Long-Term Growth Architecture
We ensure BD becomes a system, not a one-off project.
Establish a pragmatic BD operating model: stages, qualification criteria, ownership, decision gates.
Integrate BD with regulatory, clinical, market access and marketing, ensuring promises are deliverable and reputational risk controlled.
Keep all partnering decisions anchored in evidence strength, compliance and long-term value creation.
FAQ
Frequently asked questions
Who is this for?
Medtech ventures and investors who need a structured, partner-oriented commercial engine rather than ad-hoc outreach or isolated pilots.
What outcomes can we expect?
How do you work with our existing BD or sales team?
What do you need from us to start?
How quickly do we see movement?
Who is this for?
Medtech ventures and investors who need a structured, partner-oriented commercial engine rather than ad-hoc outreach or isolated pilots.